Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride, a hair loss treatment, works better and is more stable when delivered through specially prepared gels, leading to increased hair growth.

Latanoprost's effectiveness for hair growth is not confirmed but shows promise, needing more research.

Testosterone increases hamster hair growth; cyproterone acetate reduces it.

Contraceptives may affect hair growth due to estrogen, with effects varying by individual.

Topical estrogen treatments did not change hair growth in certain mouse strains, questioning previous findings on their role in hair growth control.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Male tissue has more cell death than female tissue after ischemia, and some neurosteroids only protect female cells.

Increasing light exposure in winter can make mares ovulate and cycle earlier.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

The PTGER2 gene is highly active in Cashmere goat skin and its activity changes with the hair growth cycle.

The new saw palmetto extract effectively inhibits an enzyme linked to prostate enlargement and may be as good as standard treatments.

Medroxyprogesterone acetate injections are more effective than topical ointment in treating excessive hair growth in women.

Neuroimaging suggests that treatments targeting brain steroids could help control epilepsy, especially types linked to the menstrual cycle.

Finasteride and DEHP exposure during development can change reproductive markers in rats.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Topical DHEA safely increases skin oil production.

Early hormones shape sex-specific differences in rat glands.

Neurosteroids help protect fetal brains from asphyxia damage.

Prostaglandin D2 increases testosterone levels in skin cells through reactive oxygen species, not enzymes, which could lead to new hair loss treatments.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

LMWP-PDGFA shows promise for improving hair health and treating hair loss with fewer side effects.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Applying estradiol to skin causes local changes but not cancer.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.